Individual and Institutional Corruption in European and US Healthcare: Overview and Link of Various Corruption Typologies

Abstract

In recent years, the fight against healthcare corruption has intensified. Estimates from the European Healthcare Fraud and Corruption Network calculate an approximate €56 billion annual loss to Europe as a result of corruption. To promote understanding of the complexity and interconnection of corrupt activities, we aim to present healthcare-related corruption typologies of the European Union and European Healthcare Fraud and Corruption Network. We subsequently link them to the typology of individual and institutional corruption introduced by Dennis Thompson in the context of investigating misconduct of US Congressional members. According to Thompson, individual corruption is the personal gain of individuals performing duties within an institution in exchange for nurturing private interests, while institutional corruption pertains to the failure of the institution in directing the individual’s behaviour towards the achievement of the institution’s primary purpose because the institutional design promotes the pursuit of individual goals. Effective anti-corruption activities not only require the enactment of anti-corruption laws but also the monitoring and, where appropriate, revision of institutional frameworks to prevent the undermining of the primary purposes of health systems or institutions. To gain further understanding of the similarities and differences of the three typologies, prime examples of corrupt activities in the health sector in the European Union and USA (along with their potential remedies) are provided. Linking corruption cases to Thompson’s typology revealed that many corrupt activities may show elements of both individual and institutional corruption because they are intertwined, partly overlap and may occur jointly. Hence, sanctioning individual actors only does not target the problem.

Opportunities for Use of Blockchain Technology in Medicine

“…While financial and business industries will likely be the first to adopt this technology, healthcare systems and drug supply chains in particular remain vulnerable to fraud and corruption and are thus expected to take advantage of this technology in the near future. [29,30] Although there is presently very little proof of concept and an obvious lack of literature regarding health care use cases of blockchain, there are already several prototypes built by startup companies. One such project, built by Chronicled, Inc. utilizes near field communication (NFC) technology embedded adhesive seals that are verified on a blockchain to ensure product identification.…”

Are health care scams infectious? Empirical evidence on contagion in health care fraud

“…Second, the health economics literature has been concerned with analyzing the benefits and funding of health services, with an increasing focus on cost-containment over time (Berwick & Hackbarth, 2012;Morris, 2009;Rai, 2001). Within the cost containment focus has been the attention on limiting or eliminating health care fraud (see Drabiak & Wolfson, 2020;Fan, Zhang, & Fan, 2019;Savino & Turvey, 2018). In this overall spectrum of scholarship, there has been limited or no formal attention to spatial spillovers of health care fraud and the present work attempts to make a contribution.…”

“…example, corruption could increase payoffs and lower costs of fraud (by reducing the chances of getting caught or reducing punishment upon being apprehended), both of which would support Hypothesis 2. The chances of corrupt government officials facilitating health fraud are greater when certain health programs, such as Medicaid and Medicare, are administered by the government, as in the United States (seeJesilow et al, 1993;Savino & Turvey, 2018;Sommersguter-Reichmann et al, 2018).…”

Analysis of the dynamics of expenditures on pharmaceutical support of population in Ukraine, Belarus republic and in European Union

“…One of the most important areas of perspective research is conducting of factor analysis, which involves the use of the method of integrated and systematic study and measurement of the impact of equal factors on the indicator that we considered. As well known, the system of pharmaceutical supply of any state is objectively under the influence of a whole range of factors, including corruption, and the assessment of the influence of these factors ac-quires an urgent social significance [11][12][13][14].…”